What You Should Know: - New company Velsera was announced at the J.P. Morgan Healthcare Conference supported by thematic-focused impact fund Summa Equity (“Summa”). - Velsera sets out to amplify the impact of clinicians, researchers and scientists for the benefit of patients around the world. Velsera creates a software platform out of science, technology, and informatics, making data actionable, accelerating the pace and potential of multi-omics. - Velsera, headquartered in
Read More
genomics
Liver Cancer Awareness – Here’s What You Need to Know in 2023
By the end of 2022, nearly 42,00 new cases of primary liver cancer will be diagnosed in the United States. In fact, liver cancer incidence rates have more than tripled since 1980, marking an increased need for better detection and diagnosis. We might not talk about liver cancer as much as we do breast or lung cancer, but it’s a real threat to millions of Americans – and we need to continue spreading awareness. Early detection is especially critical in treating liver cancer.
Read More
C2i Genomics & AstraZeneca Partner to Advance Cancer Therapy
What You Should Know: - C2i Genomics, a cancer intelligence company, today announced a strategic collaboration with AstraZeneca, a global life sciences and pharmaceutical leader. - The two companies have collaborated to evaluate the potential of whole-genome minimal residual disease (MRD) testing across solid cancers. - Expanding on a completion of AstraZeneca’s accelerator BeyondBio SCALE program for start-ups and successful technology validation, C2i Genomics and AstraZeneca
Read More
WellSpan Health & Helix to Create Population Genomics Program
What You Should Know: - WellSpan Health and Helix, the nation’s leading population genomics and viral surveillance company, announced today a partnership to create a comprehensive population genomics program designed to improve patient healthcare outcomes by integrating genetic insights into clinical care and research. - Patients who are interested can have a DNA sample collected to generate genomic data. Once obtained, with their consent, the results from their sample will be integrated
Read More
JPMorgan Establishes Life Sciences Private Equity Division
What You Should Know: - J.P. Morgan Asset Management announced the establishment of a new life sciences private equity team, Life Sciences Private Capital. - The new team will focus on investing in both early and growth-stage healthcare companies across multiple strategies aligned to specific market opportunities, with a focus on novel therapeutics and technologies in several target areas including Genetic Medicine, Oncology, Neurodegenerative Disease, Rare Diseases, Autoimmunity,
Read More
Mount Sinai Develops Employee Health Contact Tracing Database to Mitigate COVID-19 Spread
What You Should Know: - Mount Sinai researchers have developed an Employee Health COVID-19 REDCap Registry to address the need for contact tracing and agile exposure investigations to mitigate the spread of COVID-19 among hospital staff. - Employee Health COVID-19 REDCap Registry is a cloud-based digital framework using the Research Electronic Data Capture web application—to track and reduce the spread of the virus across the Mount Sinai Health System including 8 hospitals and more than
Read More
Tavros Therapeutics Raises $7.5M to Develop Targeted Cancer Therapies
What You Should Know: - Tavros Therapeutics, a precision oncology platform company leading the new frontier of targeted therapies exploiting tumors’ genetic vulnerabilities raises $7.5 million in Seed II financing co-led by existing investor Piedmont Capital Investments and new investor KdT Ventures, with participation from Alexandria Venture Investments. - Tavros launched in 2020 with a $3 million seed financing by Piedmont Capital Investments and a strategic collaboration with Zentalis
Read More
Techstars Relaunches Healthcare Accelerator in Los Angeles
What You Should Know: - Techstars, a global investment business that provides access to capital, one-on-one mentorship, and customized programming for early-stage entrepreneurs announces today the relaunch of Techstars Healthcare sponsored by Cedars-Sinai, Point32Health, UCI Health, and UnitedHealthcare. - The consortium-led accelerator program will be based in Los Angeles and select 12 high-growth startups to participate in its intensive 13-week program. Startups will receive capital,
Read More
Pharmacogenomics: The Key to Unlocking the Future of Personalized Healthcare
Pharmacogenomics—the study of genetic influences on an individual's response to therapeutic medications—is an area of personalized medicine that is gaining momentum. Although pharmacogenomics has been around for a while, providers, health plans, pharmacists and legislators are developing a greater appreciation for its potential benefits and applications. How Can Pharmacogenomics Improve Outcomes? By considering a person’s DNA in treatment options, providers can determine how an
Read More
KLAS: 7 Key Healthcare Trends in Microsoft Cloud Technologies in 2022
What You Should Know: - A new report from KLAS focuses on healthcare-specific deployments of Microsoft Cloud Technologies, especially Microsoft Azure, which is receiving strong market interest. - This study is meant to help organizations considering Microsoft Cloud technologies understand their current use, the overall customer experience, and the impact of the solutions. Key Healthcare Trends in Microsoft Cloud Technologies in 2022 While still early, healthcare is gaining momentum
Read More
